Annual Cash & Cash Equivalents
$9.64 M
+$5.01 M+108.12%
December 31, 2023
Summary
- As of February 7, 2025, NSPR annual cash & cash equivalents is $9.64 million, with the most recent change of +$5.01 million (+108.12%) on December 31, 2023.
- During the last 3 years, NSPR annual cash & cash equivalents has fallen by -$3.00 million (-23.76%).
- NSPR annual cash & cash equivalents is now -45.02% below its all-time high of $17.54 million, reached on December 31, 2013.
Performance
NSPR Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$15.82 M
-$12.57 M-44.27%
September 30, 2024
Summary
- As of February 7, 2025, NSPR quarterly cash and cash equivalents is $15.82 million, with the most recent change of -$12.57 million (-44.27%) on September 30, 2024.
- Over the past year, NSPR quarterly cash and cash equivalents has increased by +$1.98 million (+14.30%).
- NSPR quarterly cash and cash equivalents is now -64.08% below its all-time high of $44.03 million, reached on March 31, 2021.
Performance
NSPR Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
NSPR Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +108.1% | +14.3% |
| 3 y3 years | -23.8% | +21.1% |
| 5 y5 years | +2.7% | +14.1% |
NSPR Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -19.7% | +108.1% | -44.3% | +302.1% |
| 5 y | 5-year | -23.8% | +108.1% | -64.1% | +403.6% |
| alltime | all time | -45.0% | >+9999.0% | -64.1% | -100.0% |
InspireMD Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $15.82 M(-44.3%) |
| Jun 2024 | - | $28.39 M(+202.3%) |
| Mar 2024 | - | $9.39 M(-2.6%) |
| Dec 2023 | $9.64 M(+108.1%) | $9.64 M(-30.3%) |
| Sep 2023 | - | $13.84 M(+19.9%) |
| Jun 2023 | - | $11.54 M(+173.1%) |
| Mar 2023 | - | $4.23 M(-8.7%) |
| Dec 2022 | $4.63 M(-61.4%) | $4.63 M(+17.7%) |
| Sep 2022 | - | $3.93 M(-38.5%) |
| Jun 2022 | - | $6.39 M(-18.0%) |
| Mar 2022 | - | $7.80 M(-35.0%) |
| Dec 2021 | $12.00 M(-5.1%) | $12.00 M(-8.1%) |
| Sep 2021 | - | $13.06 M(-68.5%) |
| Jun 2021 | - | $41.42 M(-5.9%) |
| Mar 2021 | - | $44.03 M(+248.2%) |
| Dec 2020 | $12.64 M(+129.3%) | $12.64 M(+16.2%) |
| Sep 2020 | - | $10.88 M(-21.5%) |
| Jun 2020 | - | $13.86 M(+341.3%) |
| Mar 2020 | - | $3.14 M(-43.0%) |
| Dec 2019 | $5.51 M(-41.2%) | $5.51 M(-22.9%) |
| Sep 2019 | - | $7.15 M(+48.3%) |
| Jun 2019 | - | $4.82 M(-16.9%) |
| Mar 2019 | - | $5.81 M(-38.1%) |
| Dec 2018 | $9.38 M(+152.9%) | $9.38 M(-16.6%) |
| Sep 2018 | - | $11.25 M(+74.6%) |
| Jun 2018 | - | $6.44 M(+38.9%) |
| Mar 2018 | - | $4.64 M(+25.0%) |
| Dec 2017 | $3.71 M | $3.71 M(-22.1%) |
| Sep 2017 | - | $4.76 M(-30.7%) |
| Jun 2017 | - | $6.88 M(-19.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $8.57 M(+14.1%) |
| Dec 2016 | $7.52 M(+130.8%) | $7.52 M(-28.2%) |
| Sep 2016 | - | $10.47 M(+1082.8%) |
| Jun 2016 | - | $885.00 K(-55.7%) |
| Mar 2016 | - | $2.00 M(-38.6%) |
| Dec 2015 | $3.26 M(-48.3%) | $3.26 M(-50.0%) |
| Sep 2015 | - | $6.51 M(-33.4%) |
| Jun 2015 | - | $9.77 M(-25.9%) |
| Mar 2015 | - | $13.19 M(+109.3%) |
| Dec 2014 | $6.30 M(-64.1%) | $6.30 M(+26.6%) |
| Sep 2014 | - | $4.98 M(-44.6%) |
| Jun 2014 | - | $8.99 M(-34.4%) |
| Mar 2014 | - | $13.71 M(+19.8%) |
| Dec 2013 | $17.54 M(+18.3%) | - |
| Sep 2013 | - | $11.44 M(-22.8%) |
| Jun 2013 | - | $14.82 M(+489.5%) |
| Jun 2013 | $14.82 M(+44.1%) | - |
| Mar 2013 | - | $2.51 M(-53.7%) |
| Dec 2012 | - | $5.43 M(-34.5%) |
| Sep 2012 | - | $8.30 M(+147.6%) |
| Jun 2012 | $10.28 M(+101.9%) | - |
| Mar 2012 | - | $3.35 M(-34.2%) |
| Dec 2011 | $5.09 M(>+9900.0%) | $5.09 M(-31.9%) |
| Sep 2011 | - | $7.49 M(-7.2%) |
| Jun 2011 | - | $8.07 M(-16.1%) |
| Mar 2011 | - | $9.62 M(>+9900.0%) |
| Dec 2010 | - | $0.00(-100.0%) |
| Sep 2010 | - | $900.00(-84.7%) |
| Jun 2010 | $5900.00(+20.4%) | $5900.00(-65.1%) |
| Mar 2010 | - | $16.90 K(+244.9%) |
| Jun 2009 | $4900.00 | $4900.00 |
FAQ
- What is InspireMD annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for InspireMD?
- What is InspireMD annual cash & cash equivalents year-on-year change?
- What is InspireMD quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for InspireMD?
- What is InspireMD quarterly cash and cash equivalents year-on-year change?
What is InspireMD annual cash & cash equivalents?
The current annual cash & cash equivalents of NSPR is $9.64 M
What is the all time high annual cash & cash equivalents for InspireMD?
InspireMD all-time high annual cash & cash equivalents is $17.54 M
What is InspireMD annual cash & cash equivalents year-on-year change?
Over the past year, NSPR annual cash & cash equivalents has changed by +$5.01 M (+108.12%)
What is InspireMD quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of NSPR is $15.82 M
What is the all time high quarterly cash and cash equivalents for InspireMD?
InspireMD all-time high quarterly cash and cash equivalents is $44.03 M
What is InspireMD quarterly cash and cash equivalents year-on-year change?
Over the past year, NSPR quarterly cash and cash equivalents has changed by +$1.98 M (+14.30%)